Requirements of Propofol With Target Controlled Infusions for Supraglottic Airway Devices
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
to evaluate and compare the effect-site concentration of propofol with the TCI system for
second-generation SGA device insertion between the I-gel™, Supreme™, ProSeal™ and Laryngeal
Tube Suction II™.
to determine the hemodynamic changes during insertion of supraglottic devices in patients
undergoing elective surgery and any complications after device insertion.